Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
So what: Athenahealth earned $0.18 per share in the quarter, higher than the $0.13 estimated by analysts. With 34% of shares sold short, it appears a short squeeze is magnifying the move upward.
Now what: The market has been visibly bearish on Athenahealth considering the huge short interest. This is two consecutive quarters the company has beaten estimates, which is always a plus, but I'm wary of buying on a short-squeeze spike. This Fool will sit out this spike and watch for a better opportunity.
Interested in more info on Athenahealth? Add it to your watchlist by clicking here.
Fool contributor Travis Hoium does not have a position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings or follow his CAPS picks at TMFFlushDraw.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.